Ulipristal acetate

Trade Name: 
Fibristal
Manufacturer/Distributor: 
Actavis Specialty Pharmaceuticals
1-855-892-8766 www.fibristal.ca
Classification: 
Selective progesterone receptor modulator
ATC Class: 
G03AD02 - Ulipristal
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2013/06/25
Date Marketed in Canada (yyyy/mm/dd): 
2013/07/23
Presentation: 
Tablet: 5 mg. DIN: 02408163
Comments: 
Ulipristal is indicated for the treatment of moderate to severe signs and symptoms of uterine fibroids in adult women of reproductive age who are eligible for surgery. The duration of treatment is limited to three months.